These compounds may interact with:
Tyrosine-protein phosphatase non-receptor type 5
Potentially involved in: carcinoma; nerve degeneration; schizophrenia; adult high grade glioma; astrocytic glioma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; ependymoma; glioblastoma; group 3 medulloblastoma; intraductal papillary-mucinous neoplasm (ipmn); medulloblastoma, large-cell; oligodendroglioma; pick disease
Disease data sourced from Pharos.